Verana Health Expands Site Explorer With Real-World Urology Data

Verana Health®, a digital health company focused on transforming clinical research through real-world data (RWD), has announced a major update to its Site Explorer application.

The platform now includes exclusive data from urology practices, in addition to ophthalmology, enabling faster site identification, smarter protocol design, and more representative patient enrollment.

What’s New in Site Explorer?

With the latest update, Site Explorer helps trial sponsors and CROs:

• Identify study sites with specific urology and ophthalmology patient populations
• Model the impact of inclusion and exclusion criteria on eligible patients
• Reduce recruitment timelines and avoid mismatched enrollment
• Build cohorts that reflect real-world subpopulation demographics

The platform also provides practice-level intelligence, including:

• Prior research experience
• Clinician subspecialty
• Anonymized patient demographics

Powered by the Largest Specialty Registries

Verana Health’s Site Explorer is built on exclusive partnerships with:

• AAO IRIS® Registry (ophthalmology)
• AUA Quality (AQUA)® Registry (urology)

Together, these registries provide access to electronic health record data from more than 90 million de-identified patients, contributed by over 20,000 clinicians.

The dataset is refreshed regularly, giving research teams timely, longitudinal insights to support faster and more accurate site selection.

Why Real-World Data Matters for Clinical Trials?

According to Verana Health, trials designed with real-world data start with a stronger foundation. By understanding how patients are actually treated in routine care, sponsors can:

• Avoid enrollment mismatches
• Anticipate safety and feasibility challenges
• Reduce costly delays driven by unrealistic protocols

Sujay Jadhav, CEO of Verana Health, emphasized that expanding Site Explorer with urology data equips research teams to design studies that better reflect real patient populations and improve the relevance of future therapies.

Expanding Access and Diversity in Trial Recruitment

Site Explorer includes data from a broad mix of community-based practices, not just traditional research centers.

This enables life sciences companies to:

• Engage trial-naïve sites
• Reach patients within their local communities
• Improve diversity, enrollment speed, and retention

Clinical advisor Dr. Jennifer Bepple noted that involving community practices can expand patient access while strengthening trial performance.

Accelerating Evidence Generation Across Specialties

With expanded urology coverage, Site Explorer now supports smarter trial planning across two major therapeutic areas.

By combining physician expertise, artificial intelligence, and the world’s largest specialty registries, Verana Health continues to position real-world data as a core driver of faster, more representative, and more efficient clinical research.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!